Tilray Inc (Class 2) (TLRY)

$5.90USD

+$5.90 (+590.00%)

today (15 min delay)

About TLRY

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

CEO

Brendan Kennedy, MBA

Headquarters

Canada

Employees

1.65K

Revenue (TTM)

167M

Gross Profit

19.16%

Earnings

-339.22%

Cash

$96.8M

Debt

$469M

TLRY related news

    Popular on Wealthsimple

      Investing on autopilot

      Put your money on autopilot

      Invest in an intelligent portfolio of low-fee funds that are designed to meet your financial goals.

      • Low Fees - Pay an annual management fee of 0.50% (or 0.40% for accounts over £100K)

      • Stay on track - We'll instantly rebalance your portfolio and put your stock dividends back to work, earning you more

      • Human advice - We're loved for our technology. But we also have smart people to answer any questions or give advice when you need it.

      • Easy access - Manage your accounts from anywhere with our award-winning website and mobile app

      Clock

      Start investing in 5 minutes

      1. Answer a few questions about your goals and risk tolerance
      2. We'll recommend a portfolio that's right for you
      3. Connect your bank account and make a deposit

      Clicking get started accepts terms of use.